Department of Endocrinology & Diabetes, University Hospital Aintree, Liverpool, UK.
Clin Endocrinol (Oxf). 2014 Mar;80(3):419-24. doi: 10.1111/cen.12307. Epub 2013 Aug 26.
To study the presentation, management and outcomes and to apply retrospectively the Pituitary Apoplexy Score (PAS) (United Kingdom (UK) guidelines for management of apoplexy) to a large, single-centre series of patients with acute pituitary apoplexy.
Retrospective analysis of casenotes at a single neurosurgical centre in Liverpool, UK.
Fifty-five patients [mean age, 52·4 years; median duration of follow-up, 7 years] were identified; 45 of 55 (81%) had nonfunctioning adenomas, four acromegaly and six prolactinomas. Commonest presenting features were acute headache (87%), diplopia (47·2%) and visual field (VF) defects (36%). The most frequent ocular palsy involved the 3rd nerve (81%), followed by 6th nerve (34·6%) and multiple palsies (19%). Twenty-three patients were treated conservatively, and the rest had surgery either within 7 days of presentation or delayed elective surgery. Indications for surgery were deteriorating visual acuity and persistent field defects. Patients presenting with VF defects (n = 20) were more likely to undergo surgery (75%) than to be managed expectantly (25%). There was no difference in the rates of complete/near-complete resolution of VF deficits and cranial nerve palsies between those treated conservatively and those who underwent surgery. Endocrine outcomes were also similar. We were able to calculate the PAS for 46 patients: for the group treated with early surgery mean, PAS was 3·8 and for those managed conservatively or with delayed surgery was 1·8.
Patients without VF deficits or whose visual deficits are stable or improving can be managed expectantly without negative impact on outcomes. Clinical severity based on a PAS ≥ 4 appeared to influence management towards emergency surgical intervention.
研究表现、管理和结果,并回顾性地将垂体卒中评分(PAS)(英国(UK)关于卒中管理的指南)应用于一大组来自单一中心的急性垂体卒中患者系列。
英国利物浦单一神经外科中心的病例回顾分析。
共确定了 55 例患者[平均年龄 52.4 岁;中位随访时间为 7 年];55 例中有 45 例(81%)为无功能腺瘤,4 例为肢端肥大症,6 例为催乳素瘤。最常见的首发症状为急性头痛(87%)、复视(47.2%)和视野(VF)缺损(36%)。最常见的眼部麻痹涉及第 3 对神经(81%),其次是第 6 对神经(34.6%)和多对神经麻痹(19%)。23 例患者接受保守治疗,其余患者在发病后 7 天内或择期行手术治疗。手术指征为视力下降和持续存在视野缺损。有 VF 缺损的患者(n=20)更可能接受手术(75%),而不是保守治疗(25%)。保守治疗和手术治疗患者的 VF 缺损和颅神经麻痹完全/接近完全缓解率无差异。内分泌结局也相似。我们能够计算出 46 例患者的 PAS:早期手术组的平均 PAS 为 3.8,而保守治疗或择期手术组的平均 PAS 为 1.8。
无 VF 缺损或 VF 缺损稳定或改善的患者可予保守治疗,不会对结局产生负面影响。基于 PAS≥4 的临床严重程度似乎影响了管理决策,倾向于紧急手术干预。